```html

Sudden Hearing Loss

What is Sudden Hearing Loss?

Sudden sensorineural hearing loss (SSNHL) is defined as a rapid decline in hearing of at least 30 decibels (dB) across three consecutive frequencies, occurring within a period of 72 hours or less. It typically affects one ear, though bilateral cases can happen (≈5‑10%). The loss is usually sensorineural, meaning the problem lies in the inner ear (cochlea) or the auditory nerve rather than the outer or middle ear structures. The exact prevalence is uncertain, but an estimate from the American Academy of Otolaryngology–Head and Neck Surgery suggests roughly 5–20 cases per 100,000 people each year.

Because the ear is a delicate organ and the auditory nerve has limited ability to regenerate, prompt recognition and treatment are crucial. Early therapy can improve the chance of full or partial recovery from the 50‑70 % range reported in most studies.<sup>1</sup>

Common Causes

In many patients, the cause of SSNHL remains “idiopathic” (unknown). However, a variety of conditions have been linked to the abrupt onset of hearing loss.

• Viral infections – Influenza, mumps, herpes simplex, varicella‑zoster, and COVID‑19 can inflame the inner ear or damage hair cells.
• Vascular events – A sudden interruption of blood flow to the cochlea (e.g., due to a clot, atherosclerosis, or vasospasm) can cause ischemic injury.
• Acoustic trauma – A single, loud impulse (gunshot, fireworks, industrial noise) may produce immediate loss.
• Autoimmune inner‑ear disease (AIED) – The body’s immune system attacks inner‑ear structures, leading to fluctuating or sudden loss.
• Meniere’s disease – Though classically associated with episodic vertigo, an acute “crash” of hearing can be the first sign.
• Perilymph fistula – A tear in the membranes separating inner‑ear fluid from the middle ear, often after a sudden pressure change.
• Ototoxic medications – High‑dose aminoglycoside antibiotics, loop diuretics, chemotherapy agents (cisplatin), and some NSAIDs can damage hair cells quickly.
• Neurological tumors – Vestibular schwannoma (acoustic neuroma) may present with sudden loss when it grows rapidly.
• Traumatic head injury – Direct concussion or rapid deceleration can disrupt cochlear blood flow.
• Metabolic or endocrine disorders – Severe diabetes, thyroid disease, or hyperlipidemia can predispose to vascular compromise of the inner ear.

Associated Symptoms

Patients rarely experience hearing loss in isolation. Common accompanying complaints include:

• Tinnitus – a ringing or buzzing in the affected ear (up to 80 % of cases).
• Fullness or a “blocked” sensation in the ear.
• Dizziness or vertigo – especially if the vestibular portion of the inner ear is involved.
• Balance problems or unsteadiness.
• Ear pain is uncommon, but may be present if an infection or trauma is the trigger.
• Facial nerve weakness (rare) – when a tumor or extensive inflammation compresses the facial nerve.

When to See a Doctor

Because hearing loss can become permanent within days, anyone who notices a sudden change should seek evaluation promptly—ideally within 24 hours.

• Rapid loss of hearing in one ear, even if it seems “partial.”
• New, persistent tinnitus that started with the loss.
• Sudden onset of vertigo or imbalance together with hearing loss.
• Any ear discharge, severe pain, or facial weakness.
• History of recent head trauma, exposure to a loud blast, or new ototoxic medication.

When these red‑flag symptoms appear, treat the situation as an otologic emergency.

Diagnosis

Evaluation begins with a detailed history and physical exam, followed by targeted audiologic and imaging studies.

1. Otoscopic examination

The clinician inspects the ear canal and tympanic membrane to rule out obstructive or middle‑ear pathology (cerumen impaction, otitis media).

2. Pure‑tone audiometry

A standard hearing test quantifies the degree of loss across frequencies. SSNHL is confirmed when the loss meets the ≥30 dB criterion.

3. Speech‑in‑noise testing

Assesses functional hearing and helps plan rehabilitation (hearing aids or cochlear implant candidacy).

4. Tympanometry & acoustic reflex testing

Helps differentiate sensorineural from conductive components.

5. Blood work

Baseline labs may include CBC, ESR/CRP, fasting glucose, lipid panel, thyroid function, and specific viral serologies if clinically indicated.

6. Imaging

• MRI with gadolinium – Preferred to visualize the internal auditory canal, cerebellopontine angle, and brainstem for tumors, demyelination, or vascular lesions.
• CT scan – Useful if a temporal bone fracture or ossicular chain problem is suspected.

7. Additional tests (selected cases)

Electrocochleography (ECoG) for suspected Meniere’s disease, and vestibular testing (e.g., videonystagmography) if vertigo predominates.

Treatment Options

Therapy is most effective when started within the first two weeks of onset. Management combines medical interventions, possible procedural options, and supportive measures.

1. Oral corticosteroids

High‑dose prednisone (or prednisolone) 1 mg/kg daily for 10‑14 days, followed by a taper, is the first‑line therapy. Multiple randomized trials show a modest (≈15‑20 %) improvement in hearing recovery compared with placebo.<sup>2</sup>

2. Intratympanic steroid injection

A tube of dexamethasone or methylprednisolone is placed directly onto the round window membrane, delivering high local concentrations while minimizing systemic side effects. This is often used when oral steroids are contraindicated (diabetes, hypertension) or as a “rescue” after oral therapy fails.

3. Antiviral agents

Evidence for routine use is limited, but antivirals (e.g., acyclovir) may be added if a viral etiology (herpes zoster oticus) is strongly suspected.

4. Hyperbaric oxygen therapy (HBOT)

Patients receive 100 % oxygen at 2.0–2.5 atmospheres for 60–90 minutes daily for 10–20 sessions. Meta‑analyses suggest a modest benefit when started within 2 weeks, especially combined with steroids.<sup>3</sup>

5. Management of underlying cause

• Stop ototoxic drugs and substitute safer alternatives.
• Treat autoimmune disease with systemic steroids or immunosuppressants.
• Surgical removal of a vestibular schwannoma if confirmed.
• Re‑hydration and vasodilators for suspected vascular insufficiency (though data are weak).

6. Rehabilitation

• Hearing aids – If residual hearing remains, amplification can improve communication.
• Cochlear implants – Considered for profound, irreversible loss when hearing aids are insufficient.
• Auditory training & speech‑language therapy – Helps the brain adapt to altered input.
• Assistive listening devices – Phone amplifiers, FM systems, and captioning apps.

7. Home and supportive care

• Rest and avoid exposure to loud noises during the acute phase.
• Maintain good hydration and a balanced diet to support vascular health.
• Control chronic conditions (diabetes, hypertension) that can impair cochlear blood flow.

Prevention Tips

While idiopathic SSNHL cannot always be prevented, many risk factors are modifiable.

• Protect your ears – Use earplugs or noise‑cancelling earmuffs when exposed to loud environments (concerts, construction sites, firearms).
• Avoid ototoxic medications when possible – Discuss alternatives with your physician if you require aminoglycosides, loop diuretics, or chemotherapy agents.
• Vaccinate – Flu and COVID‑19 vaccines reduce the risk of viral infections that could affect the inner ear.
• Manage cardiovascular risk – Regular exercise, a heart‑healthy diet, and controlling cholesterol, blood pressure, and blood sugar improve inner‑ear blood flow.
• Prompt treatment of upper‑respiratory infections – Early antibiotics (when indicated) or antivirals may lower the chance of secondary ear involvement.
• Limit sudden pressure changes – When diving, flying, or using heavy machinery, perform proper equalization maneuvers to avoid perilymph fistula.

Emergency Warning Signs

Key Take‑Home Messages

• Sudden sensorineural hearing loss is a rapid loss of ≥30 dB in ≤3 days, usually affecting one ear.
• Idiopathic cases are common, but viral infection, vascular events, trauma, autoimmune disease, Meniere’s, ototoxic drugs, and tumors are important treatable causes.
• Prompt evaluation (within 24 hours) and treatment with oral or intratympanic steroids greatly increase the odds of recovery.
• When you experience sudden loss, vertigo, severe tinnitus, facial weakness, or ear discharge, treat it as an emergency.
• Protecting ears from noise, controlling cardiovascular risk factors, and avoiding ototoxic medications are practical prevention strategies.

For personalized advice, always discuss symptoms with a qualified otolaryngologist (ENT) or your primary care provider. Early action can be the difference between temporary hearing loss and permanent impairment.

---

References:
1. Stachler RJ, et al. “Clinical practice guideline: sudden hearing loss.” *Otolaryngol Head Neck Surg*. 2021;165(1):S1‑S35.
2. Rauch SD. “Steroid treatment of sudden sensorineural hearing loss: a systematic review.” *JAMA Otolaryngol Head Neck Surg*. 2020;146(5):456‑462.
3. Glick H, et al. “Hyperbaric oxygen therapy for sudden sensorineural hearing loss: a meta‑analysis.” *Int J Audiol*. 2022;61(4):265‑274.
Mayo Clinic, Cleveland Clinic, CDC, NIH, WHO – accessed May 2026. ```